Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories

Insiders have been trading these 5 stocks: (($ENPH)), (($ABT)), (($AXP)), (($LOW)) and (($BE)). Here is a breakdown of their recent trades and thei...

Enphase, Abbott, AmEx, Lowe’s, Bloom: Insider Shockwaves

Healthcare stocks are in focus this month as investors look for steady growth and clear catalysts in a market dealing with volatility and uneven se...

3 Best Healthcare Stocks to Buy in June, According to Analysts

Abitare In SpA ( ($IT:ABT) ) just unveiled an announcement. Abitare In S.p.A., the Milan-focused residential developer known for its urban regenera...

Abitare In Calls Ordinary Shareholders’ Meeting for July 20, 2026

Abitare In SpA ( ($IT:ABT) ) has issued an update. Abitare In’s board has convened an ordinary shareholders’ meeting for 20 July 2026 to seek a non...

Abitare In Calls July Shareholders’ Meeting on Proposed Subsidiary Sale to Techbau

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Nuvalent (NUVL), Abbott Laboratories (ABT) and Abivax SA Sponsore...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Nuvalent (NUVL), Abbott Laboratories (ABT) and Abivax SA Sponsored ADR (ABVX)

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, inched higher by 0.18%...

Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 5/28/2026

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, inched lower by 0.03% ...

Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 5/27/2026

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, moved higher by 0.21% ...

Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 5/26/2026

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, closed higher by 1.80%...

Schwab U.S. Dividend Equity ETF (SCHD) Latest Update

Walmart ($WMT), Abbott Laboratories ($ABT), and NextEra Energy ($NEE) are the three dividend aristocrat stocks with a Strong Buy rating on Wall Str...

3 ‘Strong Buy’ Dividend Aristocrat Stocks with 15%+ Upside, 5/22/26

The Schwab U.S. Dividend Equity ETF (SCHD), which tracks high-dividend U.S. stocks in the Dow Jones U.S. Dividend 100 Index, moved higher by 0.50% ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ABT	$88.41	-0.10%	41.96M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ABT	$88.41	-0.1%	41.96M
3
4
5
6

ABT

ABT

Get Abbott Laboratories Data in Excel

Get Abbott Laboratories Data in Excel